Changeflow GovPing Pharma & Drug Safety Hydrochloric acid salt of 5-HT2C agonist patent...
Routine Notice Added Final

Hydrochloric acid salt of 5-HT2C agonist patent application

Favicon for changeflow.com ChangeBridge: Patent Apps - Organic Chemistry (C07D)
Published
Detected
Email

Summary

USPTO published patent application US20260091039A1 for a crystalline hydrochloric acid salt of (R)-N-(2,2-difluoroethyl)-7-methyl-1,2,3,4,6,7-hexahydro-[1,4]diazepino[6,7,1-hi]indole-8-carboxamide (a 5-HT2C agonist). The application includes pharmaceutical composition claims and methods of use. Inventor: Anthony Clyde Blackburn. Application No. 19344622.

What changed

USPTO published patent application US20260091039A1 disclosing crystalline (R)—N-(2,2-difluoroethyl)-7-methyl-1,2,3,4,6,7-hexahydro-[1,4]diazepino[6,7,1-hi]indole-8-carboxamide hydrochloric acid salt (Compound 1). The application claims pharmaceutical compositions comprising the salt form and methods for therapeutic use. CPC classifications: A61K 31/5517 and C07D 487/04. Filing date: September 30, 2025.

Pharmaceutical companies developing 5-HT2C agonist compounds should review the application scope for potential freedom-to-operate implications. Patent applicants should ensure all required documentation is filed and monitor for USPTO examination actions. This publication does not grant patent rights; applicants must await substantive examination and potential issuance.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

HYDROCHLORIC ACID SALT OF A 5-HT2C AGONIST

Application US20260091039A1 Kind: A1 Apr 02, 2026

Inventors

Anthony Clyde Blackburn

Abstract

Provided is crystalline (R)—N-(2,2-difluoroethyl)-7-methyl-1,2,3,4,6,7-hexahydro-[1,4]diazepino[6,7,1-hi]indole-8-carboxamide (Compound 1) hydrochloric acid (HCl) salt. Also are provided pharmaceutical compositions comprising the salt form and methods for its use.

CPC Classifications

A61K 31/5517 C07D 487/04

Filing Date

2025-09-30

Application No.

19344622

View original document →

Named provisions

Abstract CPC Classifications Inventors

Get daily alerts for ChangeBridge: Patent Apps - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260091039A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Pharmaceutical Patent Filing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Healthcare

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.